← Leaderboards
Nicole E Scharping
University Of Pittsburgh At Pittsburgh
$450,509
Attributed
$450,509
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $96.8K · FY2017–23$100K$75K$50K$25K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$450,509 · 2
By mechanism
K00$360,441 · 1
F99$90,068 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Hassane M Zarour$16,372,397
- Robert L Ferris$24,076,317
- Dario Aa Vignali$40,087,127
- Iain Scott$7,663,600
- Lawrence P Kane$11,819,892
Others in their field
Other Emerging Leaders on “Environment”
- Valerie Koch · University Corporation For Atmospheric Res$244,517,972
- Scott Topper · Broad Institute, Inc.$77,958,806
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,503,514
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Prasant Mohapatra · University Of California At Davis$40,097,014
Research focus
EnvironmentAwardBiogenesisAcetyltransferaseBuffersCalciumCancer CellCancer Cell GrowthAffectBiological ProcessCancer TherapyCd8b1 GeneCd8-Positive T-LymphocytesCellsCellular BiologyCellular Metabolic ProcessCharacteristicsChimeric Antigen ReceptorCancer ImmunotherapyChromatinChronicCytokineDesignEpigenetic Process
Grant awards (6)
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy$96,797
K00 · FY2023 · CA · contact PI
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy$92,043
K00 · FY2022 · CA · contact PI
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy$87,329
K00 · FY2021 · CA · contact PI
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy$84,272
K00 · FY2020 · CA · contact PI
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy$44,524
F99 · FY2018 · CA · contact PI
Tumor-infiltrating T cell metabolic dysfunction and genetic reprogramming for effective immunotherapy$45,544
F99 · FY2017 · CA · contact PI